Weight Loss & GLP-1

Keep GLP-1 patients on track between monthly visits.

Injection-week check-ins, reply-gap outreach, and symptom flags from your practice number. Staff see the month on the brief before titration day.

No app for patients to install.

Book a demo See pricing

Injection-week nausea scale

  1. Day 3 after your injection: rate nausea 0 (none) to 10 (severe). Reply with one number.
  2. 6 Delivered
  3. Thanks. Your response has been shared with your care team for review before Thursday's visit.
  1. We haven't heard from you in 5 days. Still on your semaglutide plan? Reply OK, NAUSEA, or CALL.
  2. NAUSEA Delivered
  3. Noted for Thursday's visit. No dose changes by text. Your clinician will review.
  1. Vomited twice since Tuesday Delivered
  2. Flagged for your care team today. If you cannot keep fluids down, call the clinic or 911.

Patient thread

Reply-gap exposure

How many GLP-1 patients go quiet before titration day?

When replies stop mid-month, the no-show is often the first signal staff see. Adjust panel size and churn assumptions below. Patient counts are estimates, not a Helose guarantee.

Patients likely to churn (baseline) - -
Patients reply-gap outreach may retain - -

Helose monitors injection-week replies and silence between monthly visits. Clinical decisions stay in the room.

Problem

GLP-1 patients go quiet between monthly visits.

Symptoms show up mid-cycle. Staff only catch it on titration day.

  • Nausea after a dose step with no check-in until the next appointment
  • Patients stop texting back by week three; the no-show is the first signal staff see
  • Third-party coaching apps use unfamiliar numbers. Patients ignore them and still call your front desk
  1. Monthly visit
  2. Injection wk
  3. Week 2
  4. No reply
  5. Outreach
  6. Follow-up

Between monthly visits

Check-in texts, reply-gap outreach, and symptom flags on the schedule you set.

Injection-week check-in · Reply-gap outreach · Symptom routing

  • Injection week

    Day 3 after your injection: rate nausea 0 (none) to 10 (severe). Reply with one number.

    6

    Thanks. Your response has been shared with your care team for review before Thursday's visit.

  • Reply gap

    We haven't heard from you in 5 days. Still on your semaglutide plan? Reply OK, NAUSEA, or CALL.

    NAUSEA

    Noted for Thursday's visit. No dose changes by text. Your clinician will review.

  • Patient flags nausea

    Vomited twice since Tuesday

    Flagged for your care team today. If you cannot keep fluids down, call the clinic or 911.

Pre-visit brief

Open titration day with the month on one screen.

Before the monthly slot: nausea scores over the cycle, when replies stopped, and optional weight logs. What to ask first, not a coordinator scrolling texts.

  • Nausea 4 → 6 since last titration, logged Tue after injection week
  • Five-day reply gap: patient answered NAUSEA after Saturday outreach
  • Weight log 3 of 4 weeks; dose changes queued for the visit only
Pre-visit briefing Dana R. · Monthly follow-up · Thu 10 AM · titration visit

Since the last visit

  • Care plan (Mar 1): Semaglutide titration · injection-week nausea scale · optional weight log

  • Nausea trend: 4/10 at last titration → 6/10 Tue after injection week

  • Reply gap: Five days silent · answered NAUSEA after Sat outreach

  • Weight log: 3 of 4 requested weeks submitted

  • Visit priority: Symptom trajectory and titration, not disengagement

Recommended focus

  • Review nausea trend since last dose step: 6/10 logged injection week

  • Confirm hydration and meal timing before any dose change

  • Titration decision in the visit only, not by text

Integrations

Wearable recovery trends beside GLP-1 check-in replies.

Oura, WHOOP, Apple Health, and CGM data on the same brief as nausea scores and weight logs—what changed between monthly visits, not just what is in the chart.

  • Patient wearables & health data

    • Sleep, HRV, and recovery trends dated to injection week
    • Optional CGM and activity context beside reply-gap outreach
    • Deviation-from-baseline without asking patients to open another app

  • Chart & practice stack

    • Brief opens beside your EHR; chart remains the system of record
    • Titration, prior auth, and dose changes stay out of SMS
    • Licensed clinician approves outbound templates before they go live

For your team

Patients who stop replying get a text before the no-show.

  • 4 weeks between visits

    Injection-week scales and reply-gap outreach on the cadence you set at the monthly visit.

  • Fewer silent no-shows

    When patients stop replying, coordinators see it on the brief, not when the slot is empty.

  • 90 sec before titration day

    Nausea trend, reply gaps, and weight logs in one summary. Dose changes only in the room.

Helose works for HIPAA-covered clinics. BAA at onboarding. US-only infrastructure. We never train models on your PHI.

Set check-ins at the monthly visit. Side-effect and reply-gap texts go out until the next slot.

Book a demo